{"transactions":[{"id":4631980,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2026-10-02T23:12:02.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":129.9,"price":230.94,"value":29999.106,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":4108.7,"derivative":{"underlying":"Common Stock","underlying_shares":129.9},"source":{"system":"sec-edgar","filing":"0001745938-26-000005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000174593826000005/form4.xml","form_type":"4"}},{"id":5693,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2026-08-18T22:31:06.000Z","date":"2026-08-17","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is  exercisable on the third anniversary of the grant date."}],"balance_after":28712,"derivative":{"exercise_price":115.67,"exercise_date":"2020-02-13","expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000200406-26-000175","document":"wk-form4_1787092263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000175/wk-form4_1787092263.xml","form_type":"4"}},{"id":5692,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-08-18T22:31:06.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":263.36,"value":3950400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48.  The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":194451.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000175","document":"wk-form4_1787092263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000175/wk-form4_1787092263.xml","form_type":"4"}},{"id":5691,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-08-18T22:31:06.000Z","date":"2026-08-17","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":115.67,"value":1735050.0,"ownership":{"direct":true},"balance_after":209451.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000175","document":"wk-form4_1787092263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000175/wk-form4_1787092263.xml","form_type":"4"}},{"id":307509,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2026-07-02T21:56:03.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":110.99,"price":270.31,"value":30001.7069,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":3949.25,"derivative":{"underlying":"Common Stock","underlying_shares":110.99},"source":{"system":"sec-edgar","filing":"0001745938-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/63908/000174593826000003/form4.xml","form_type":"4"}},{"id":307508,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2026-07-02T21:56:03.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":96.53,"price":310.79,"value":30000.5587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":3813.63,"derivative":{"underlying":"Common Stock","underlying_shares":96.53},"source":{"system":"sec-edgar","filing":"0001745938-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000174593826000003/form4.xml","form_type":"4"}},{"id":13597,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"grant","planned":false,"acquired":true,"shares":3940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Each RSU represents a contingent right to receive one share of Company Common Stock."}],"balance_after":3940,"derivative":{"underlying":"Common Stock","underlying_shares":3940},"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13596,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"grant","planned":false,"acquired":true,"shares":54869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":54869,"derivative":{"exercise_price":243.45,"expiration_date":"2036-02-15","underlying":"Common Stock","underlying_shares":54869},"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13595,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":1847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Each RSU represents a contingent right to receive one share of Company Common Stock."}],"balance_after":3692,"derivative":{"underlying":"Common Stock","underlying_shares":1847},"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13594,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":1594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Each RSU represents a contingent right to receive one share of Company Common Stock."}],"balance_after":1594,"derivative":{"underlying":"Common Stock","underlying_shares":1594},"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13593,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Performance Share Units","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":27412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2026-02-13","underlying":"Common Stock","underlying_shares":27412},"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13592,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1302},"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13591,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":945,"price":243.45,"value":230060.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of RSUs."}],"balance_after":194451.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13590,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":1847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."}],"balance_after":195396.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13589,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":816,"price":243.45,"value":198655.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of RSUs."}],"balance_after":193549.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13588,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":1594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."}],"balance_after":194365.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13587,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":13547,"price":244.55,"value":3312918.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld for payment of taxes upon vesting of PSUs."}],"balance_after":192771.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13586,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":27412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting."}],"balance_after":206318.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13585,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":409,"price":244.55,"value":100020.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of RSUs."}],"balance_after":178906.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":13584,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2026-02-19T02:11:49.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."}],"balance_after":179315.001,"source":{"system":"sec-edgar","filing":"0000200406-26-000037","document":"wk-form4_1771467106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000037/wk-form4_1771467106.xml","form_type":"4"}},{"id":14285,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Performance Share Units","published_at":"2026-02-12T01:45:44.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":27412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026."}],"balance_after":27412,"derivative":{"exercise_date":"2026-02-13","underlying":"Common Stock","underlying_shares":27412},"source":{"system":"sec-edgar","filing":"0000200406-26-000030","document":"wk-form4_1770860741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000030/wk-form4_1770860741.xml","form_type":"4"}},{"id":315671,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2026-01-05T16:51:39.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":768.9,"price":305.63,"value":234998.907,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":3696.03,"derivative":{"underlying":"Common Stock","underlying_shares":768.9},"source":{"system":"sec-edgar","filing":"0000063908-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390826000016/form4.xml","form_type":"4"}},{"id":318463,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2025-10-01T18:34:44.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":98.72,"price":303.89,"value":30000.0208,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":2910.15,"derivative":{"underlying":"Common Stock","underlying_shares":98.72},"source":{"system":"sec-edgar","filing":"0000063908-25-000051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390825000051/form4.xml","form_type":"4"}},{"id":19971,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-09-05T22:00:47.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":56471,"price":101.87,"value":5752700.77,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vested and exercisable one day after the third anniversary of the date of the grant."}],"balance_after":0,"derivative":{"exercise_price":101.87,"exercise_date":"2019-02-09","expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":56471},"source":{"system":"sec-edgar","filing":"0000200406-25-000186","document":"wk-form4_1757109644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/wk-form4_1757109644.xml","form_type":"4"}},{"id":19970,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-09-05T22:00:47.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":56471,"price":177.806,"value":10040882.626,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $177.715 to $177.89.  The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":178013.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000186","document":"wk-form4_1757109644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/wk-form4_1757109644.xml","form_type":"4"}},{"id":19969,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-09-05T22:00:47.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":true,"shares":56471,"price":101.87,"value":5752700.77,"ownership":{"direct":true},"balance_after":234484.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000186","document":"wk-form4_1757109644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/wk-form4_1757109644.xml","form_type":"4"}},{"id":321049,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2025-07-01T19:06:12.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":102.68,"price":292.17,"value":30000.0156,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":2692.43,"derivative":{"underlying":"Common Stock","underlying_shares":102.68},"source":{"system":"sec-edgar","filing":"0001567619-25-000358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000156761925000358/form4.xml","form_type":"4"}},{"id":323419,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2025-04-02T20:54:07.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":96.04,"price":312.37,"value":30000.0148,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":2676.44,"derivative":{"underlying":"Common Stock","underlying_shares":96.04},"source":{"system":"sec-edgar","filing":"0001567619-25-000262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000156761925000262/form4.xml","form_type":"4"}},{"id":27947,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2025-02-19T22:35:20.000Z","date":"2025-02-15","kind":"grant","planned":false,"acquired":true,"shares":5539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis."}],"balance_after":5539,"derivative":{"underlying":"Common Stock","underlying_shares":5539},"source":{"system":"sec-edgar","filing":"0000200406-25-000080","document":"wk-form4_1740004513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000080/wk-form4_1740004513.xml","form_type":"4"}},{"id":27946,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-02-19T22:35:20.000Z","date":"2025-02-15","kind":"grant","planned":false,"acquired":true,"shares":89781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":89781,"derivative":{"exercise_price":156.15,"expiration_date":"2035-02-15","underlying":"Common Stock","underlying_shares":89781},"source":{"system":"sec-edgar","filing":"0000200406-25-000080","document":"wk-form4_1740004513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000080/wk-form4_1740004513.xml","form_type":"4"}},{"id":28137,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Performance Share Units","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":15465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022."}],"balance_after":0,"derivative":{"exercise_date":"2025-02-14","underlying":"Common Stock","underlying_shares":15465},"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28136,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":false,"shares":1594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Each RSU represents a contingent right to receive one share of Company Common Stock."}],"balance_after":3188,"derivative":{"underlying":"Common Stock","underlying_shares":1594},"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28135,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":4053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14,  2022 vest three years after date of grant.  The RSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14,  2022 vest three years after date of grant.  The RSUs convert into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2025-02-14","underlying":"Common Stock","underlying_shares":4053},"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28134,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Each RSU represents a contingent right to receive one share of Company Common Stock."}],"balance_after":1302,"derivative":{"underlying":"Common Stock","underlying_shares":1302},"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28133,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7911,"price":156.71,"value":1239732.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares withheld for payment of taxes upon vesting of PSUs."}],"balance_after":178013.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28132,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":15465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022."}],"balance_after":185924.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28131,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":651,"price":156.15,"value":101653.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of RSUs."}],"balance_after":170459.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28130,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":true,"shares":1594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting."}],"balance_after":171110.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28129,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1348,"price":156.71,"value":211245.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of RSUs."}],"balance_after":169516.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28128,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":4053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14,  2022 vest three years after date of grant.  The RSUs convert into shares of Common Stock upon vesting."}],"balance_after":170864.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28127,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":410,"price":155.26,"value":63656.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of RSUs."}],"balance_after":166811.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28126,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-19T02:08:02.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting."}],"balance_after":167221.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000052","document":"wk-form4_1739930875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/wk-form4_1739930875.xml","form_type":"4"}},{"id":28394,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Performance Share Units","published_at":"2025-02-12T23:18:00.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":15465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement."}],"balance_after":15465,"derivative":{"exercise_date":"2025-02-14","underlying":"Common Stock","underlying_shares":15465},"source":{"system":"sec-edgar","filing":"0000200406-25-000025","document":"wk-form4_1739402273.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000025/wk-form4_1739402273.xml","form_type":"4"}},{"id":28453,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-02-12T00:41:17.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":58504,"price":100.06,"value":5853910.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects the auto-exercise of options immediately prior to their expiration."}],"balance_after":0,"derivative":{"exercise_price":100.06,"exercise_date":"2018-02-10","expiration_date":"2025-02-09","underlying":"Common Stock","underlying_shares":58504},"source":{"system":"sec-edgar","filing":"0000200406-25-000013","document":"wk-form4_1739320870.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000013/wk-form4_1739320870.xml","form_type":"4"}},{"id":28452,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-12T00:41:17.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":47436,"price":153.12,"value":7263400.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4."}],"balance_after":165919.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000013","document":"wk-form4_1739320870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000013/wk-form4_1739320870.xml","form_type":"4"}},{"id":28451,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2025-02-12T00:41:17.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":58504,"price":100.06,"value":5853910.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the auto-exercise of options immediately prior to their expiration."}],"balance_after":213355.001,"source":{"system":"sec-edgar","filing":"0000200406-25-000013","document":"wk-form4_1739320870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000013/wk-form4_1739320870.xml","form_type":"4"}},{"id":327572,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2025-01-03T22:53:32.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":700.47,"price":289.89,"value":203059.2483,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":2565.65,"derivative":{"underlying":"Common Stock","underlying_shares":700.47},"source":{"system":"sec-edgar","filing":"0001567619-25-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000156761925000018/form4.xml","form_type":"4"}},{"id":330431,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2024-10-01T20:38:29.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":98.52,"price":304.51,"value":30000.3252,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":1751.1,"derivative":{"underlying":"Common Stock","underlying_shares":98.52},"source":{"system":"sec-edgar","filing":"0000063908-24-000141","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390824000141/form4.xml","form_type":"4"}},{"id":332465,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2024-07-01T20:37:53.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":117.72,"price":254.84,"value":29999.7648,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":1643.23,"derivative":{"underlying":"Common Stock","underlying_shares":117.72},"source":{"system":"sec-edgar","filing":"0000063908-24-000110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390824000110/form4.xml","form_type":"4"}},{"id":336015,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2024-04-02T20:04:54.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":106.4,"price":281.95,"value":29999.48,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":1515.53,"derivative":{"underlying":"Common Stock","underlying_shares":106.4},"source":{"system":"sec-edgar","filing":"0000063908-24-000086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390824000086/form4.xml","form_type":"4"}},{"id":45492,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2024-02-20T22:58:17.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":4782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":4782,"derivative":{"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":4782},"source":{"system":"sec-edgar","filing":"0001225208-24-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002536/doc4.xml","form_type":"4"}},{"id":45491,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2024-02-20T22:58:17.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":76981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":76981,"derivative":{"exercise_price":157.92,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":76981},"source":{"system":"sec-edgar","filing":"0001225208-24-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002536/doc4.xml","form_type":"4"}},{"id":46160,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Restricted Share Units","published_at":"2024-02-15T21:53:44.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date.  The Restricted Share Units converted into shares of Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date.  The Restricted Share Units converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date.  The Restricted Share Units converted into shares of Common Stock upon vesting."}],"balance_after":2604,"derivative":{"underlying":"Common Stock","underlying_shares":1302},"source":{"system":"sec-edgar","filing":"0001225208-24-002181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002181/doc4.xml","form_type":"4"}},{"id":46159,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2024-02-15T21:53:44.000Z","date":"2024-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":666,"price":157.85,"value":105128.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Restricted Share Units."}],"balance_after":154851.001,"source":{"system":"sec-edgar","filing":"0001225208-24-002181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002181/doc4.xml","form_type":"4"}},{"id":46158,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2024-02-15T21:53:44.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date.  The Restricted Share Units converted into shares of Common Stock upon vesting."}],"balance_after":155517.001,"source":{"system":"sec-edgar","filing":"0001225208-24-002181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002181/doc4.xml","form_type":"4"}},{"id":46279,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Performance Share Units","published_at":"2024-02-14T23:36:31.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":22433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-02-08","underlying":"Common Stock","underlying_shares":22433},"source":{"system":"sec-edgar","filing":"0001225208-24-002103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002103/doc4.xml","form_type":"4"}},{"id":46278,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2024-02-14T23:36:31.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":13403,"price":157.4,"value":2109632.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board."}],"balance_after":154215.001,"source":{"system":"sec-edgar","filing":"0001225208-24-002103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002103/doc4.xml","form_type":"4"}},{"id":46277,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2024-02-14T23:36:31.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":3769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares earned due to performance factor of 116.8% upon certification of performance results by the Board."}],"balance_after":167618.001,"source":{"system":"sec-edgar","filing":"0001225208-24-002103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002103/doc4.xml","form_type":"4"}},{"id":46276,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WWC. Innovative Medicine"}}],"security":"Common Stock","published_at":"2024-02-14T23:36:31.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":22433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024."}],"balance_after":163849.001,"source":{"system":"sec-edgar","filing":"0001225208-24-002103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824002103/doc4.xml","form_type":"4"}},{"id":46547,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2024-02-13T00:25:22.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":59397,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":90.44,"exercise_date":"2017-02-11","expiration_date":"2024-02-09","underlying":"Common Stock","underlying_shares":59397},"source":{"system":"sec-edgar","filing":"0001225208-24-001900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/doc4.xml","form_type":"4"}},{"id":46546,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2024-02-13T00:25:22.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":3739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2024-02-08","underlying":"Common Stock","underlying_shares":3739},"source":{"system":"sec-edgar","filing":"0001225208-24-001900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/doc4.xml","form_type":"4"}},{"id":46545,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2024-02-13T00:25:22.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":59397,"price":156.27,"value":9281969.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $156.180 to $156.360. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":141416.001,"source":{"system":"sec-edgar","filing":"0001225208-24-001900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/doc4.xml","form_type":"4"}},{"id":46544,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2024-02-13T00:25:22.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":59397,"price":90.44,"value":5371864.68,"ownership":{"direct":true},"balance_after":200813.001,"source":{"system":"sec-edgar","filing":"0001225208-24-001900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/doc4.xml","form_type":"4"}},{"id":46543,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2024-02-13T00:25:22.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1913,"price":156.33,"value":299059.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Restricted Share Units."}],"balance_after":141416.001,"source":{"system":"sec-edgar","filing":"0001225208-24-001900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/doc4.xml","form_type":"4"}},{"id":46542,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2024-02-13T00:25:22.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":3739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."}],"balance_after":143329.001,"source":{"system":"sec-edgar","filing":"0001225208-24-001900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/doc4.xml","form_type":"4"}},{"id":343123,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2024-01-03T21:20:12.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":775.69,"price":296.51,"value":229999.8419,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":1400.75,"derivative":{"underlying":"Common Stock","underlying_shares":775.69},"source":{"system":"sec-edgar","filing":"0000063908-24-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390824000018/form4.xml","form_type":"4"}},{"id":345476,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2023-10-03T20:33:57.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":109.13,"price":263.44,"value":28749.2072,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":615.26,"derivative":{"underlying":"Common Stock","underlying_shares":109.13},"source":{"system":"sec-edgar","filing":"0000063908-23-000093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390823000093/form4.xml","form_type":"4"}},{"id":347869,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2023-07-05T21:01:49.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":96.34,"price":298.41,"value":28748.8194,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":503.37,"derivative":{"underlying":"Common Stock","underlying_shares":96.34},"source":{"system":"sec-edgar","filing":"0000063908-23-000068","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390823000068/form4.xml","form_type":"4"}},{"id":350576,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2023-04-04T18:18:34.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":102.82,"price":279.61,"value":28749.5002,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":404.92,"derivative":{"underlying":"Common Stock","underlying_shares":102.82},"source":{"system":"sec-edgar","filing":"0000063908-23-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000006390823000026/form4.xml","form_type":"4"}},{"id":58940,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2023-02-16T00:25:12.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":3906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3906,"derivative":{"underlying":"Common Stock","underlying_shares":3906},"source":{"system":"sec-edgar","filing":"0001225208-23-002065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823002065/doc4.xml","form_type":"4"}},{"id":58939,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-02-16T00:25:12.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":64634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":64634,"derivative":{"exercise_price":162.75,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":64634},"source":{"system":"sec-edgar","filing":"0001225208-23-002065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823002065/doc4.xml","form_type":"4"}},{"id":58938,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2023-02-16T00:25:12.000Z","date":"2023-02-13","kind":"tax_withholding","acquired":false,"shares":10569,"price":162.01,"value":1712283.69,"ownership":{"direct":true},"balance_after":139590.001,"source":{"system":"sec-edgar","filing":"0001225208-23-002065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823002065/doc4.xml","form_type":"4"}},{"id":58937,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2023-02-16T00:25:12.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":21422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020."}],"balance_after":150159.001,"source":{"system":"sec-edgar","filing":"0001225208-23-002065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823002065/doc4.xml","form_type":"4"}},{"id":59077,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2023-02-14T21:36:18.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":3570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2023-02-10","underlying":"Common Stock","underlying_shares":3570},"source":{"system":"sec-edgar","filing":"0001225208-23-001907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823001907/doc4.xml","form_type":"4"}},{"id":59076,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2023-02-14T21:36:18.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":1289,"price":162.08,"value":208921.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Restricted Share Units."}],"balance_after":128737.001,"source":{"system":"sec-edgar","filing":"0001225208-23-001907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823001907/doc4.xml","form_type":"4"}},{"id":59075,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2023-02-14T21:36:18.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":3570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting."}],"balance_after":130026.001,"source":{"system":"sec-edgar","filing":"0001225208-23-001907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520823001907/doc4.xml","form_type":"4"}},{"id":355262,"issuer":{"id":2849,"kind":"organization","name":"MCDONALDS CORP"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2023-01-04T20:00:17.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":300.39,"price":263.53,"value":79161.7767,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the \"Plan\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1).  Amount represents deferred compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Payment of phantom stock will occur following the Director's retirement date or other termination from the Board."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares acquired through dividend reinvestment."}],"balance_after":300.39,"derivative":{"underlying":"Common Stock","underlying_shares":300.39},"source":{"system":"sec-edgar","filing":"0001567619-23-000182","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/63908/000156761923000182/doc1.xml","form_type":"4"}},{"id":61309,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-11-23T21:44:21.000Z","date":"2022-11-22","kind":"exercise","acquired":false,"shares":76923,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":72.54,"exercise_date":"2016-01-17","expiration_date":"2023-01-13","underlying":"Common Stock","underlying_shares":76923},"source":{"system":"sec-edgar","filing":"0001225208-22-011890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822011890/doc4.xml","form_type":"4"}},{"id":61308,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2022-11-23T21:44:21.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":76923,"price":176.7794,"value":13598401.7862,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $176.525 to $177.190. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":126456.001,"source":{"system":"sec-edgar","filing":"0001225208-22-011890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822011890/doc4.xml","form_type":"4"}},{"id":61307,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2022-11-23T21:44:21.000Z","date":"2022-11-22","kind":"exercise","acquired":true,"shares":76923,"price":72.54,"value":5579994.42,"ownership":{"direct":true},"balance_after":203379.001,"source":{"system":"sec-edgar","filing":"0001225208-22-011890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822011890/doc4.xml","form_type":"4"}},{"id":70390,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Performance Share Units","published_at":"2022-02-17T11:01:16.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":18064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited."}],"balance_after":1721,"derivative":{"exercise_date":"2022-02-11","underlying":"Common Stock","underlying_shares":18064},"source":{"system":"sec-edgar","filing":"0001225208-22-002377","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/doc4.xml","form_type":"4"}},{"id":70389,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2022-02-17T11:01:16.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":4053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan.  Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan.  Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant."}],"balance_after":4053,"derivative":{"exercise_date":"2025-02-14","underlying":"Common Stock","underlying_shares":4053},"source":{"system":"sec-edgar","filing":"0001225208-22-002377","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/doc4.xml","form_type":"4"}},{"id":70388,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-02-17T11:01:16.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":80055,"price":165.89,"value":13280323.95,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan."},{"field":"date","element":"transactionDate","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan."}],"balance_after":80055,"derivative":{"exercise_date":"2025-02-14","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":80055},"source":{"system":"sec-edgar","filing":"0001225208-22-002377","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/doc4.xml","form_type":"4"}},{"id":70387,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2022-02-17T11:01:16.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":8841,"price":165.89,"value":1466633.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Performance Share Units."}],"balance_after":126456.001,"source":{"system":"sec-edgar","filing":"0001225208-22-002377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/doc4.xml","form_type":"4"}},{"id":70386,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2022-02-17T11:01:16.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":18064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."}],"balance_after":135297.001,"source":{"system":"sec-edgar","filing":"0001225208-22-002377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/doc4.xml","form_type":"4"}},{"id":70866,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2022-02-16T01:02:45.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":3297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2022-02-11","underlying":"Common Stock","underlying_shares":3297},"source":{"system":"sec-edgar","filing":"0001225208-22-002211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002211/doc4.xml","form_type":"4"}},{"id":70865,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2022-02-16T01:02:45.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":1190,"price":168.85,"value":200931.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Restricted Share Units."}],"balance_after":117233.001,"source":{"system":"sec-edgar","filing":"0001225208-22-002211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002211/doc4.xml","form_type":"4"}},{"id":70864,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2022-02-16T01:02:45.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":3297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."}],"balance_after":118423.001,"source":{"system":"sec-edgar","filing":"0001225208-22-002211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002211/doc4.xml","form_type":"4"}},{"id":93090,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2021-02-18T00:09:19.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":2177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2021-02-12","underlying":"Common Stock","underlying_shares":2177},"source":{"system":"sec-edgar","filing":"0001225208-21-002854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/doc4.xml","form_type":"4"}},{"id":93089,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Performance Share Units","published_at":"2021-02-18T00:09:19.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":11429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2021-02-12","underlying":"Common Stock","underlying_shares":11429},"source":{"system":"sec-edgar","filing":"0001225208-21-002854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/doc4.xml","form_type":"4"}},{"id":93088,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2021-02-18T00:09:19.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":5268,"price":165.55,"value":872117.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld for payment of taxes upon vesting of Performance Share Units."}],"balance_after":115126.001,"source":{"system":"sec-edgar","filing":"0001225208-21-002854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/doc4.xml","form_type":"4"}},{"id":93087,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2021-02-18T00:09:19.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":797,"price":165.55,"value":131943.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of Restricted Share Units."}],"balance_after":120394.001,"source":{"system":"sec-edgar","filing":"0001225208-21-002854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/doc4.xml","form_type":"4"}},{"id":93086,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2021-02-18T00:09:19.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":2177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting."}],"balance_after":121191.001,"source":{"system":"sec-edgar","filing":"0001225208-21-002854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/doc4.xml","form_type":"4"}},{"id":93085,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2021-02-18T00:09:19.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":11429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting."}],"balance_after":119014.001,"source":{"system":"sec-edgar","filing":"0001225208-21-002854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/doc4.xml","form_type":"4"}},{"id":93662,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2021-02-10T23:47:12.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":3739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan.  Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan.  Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant."}],"balance_after":3739,"derivative":{"exercise_date":"2024-02-08","underlying":"Common Stock","underlying_shares":3739},"source":{"system":"sec-edgar","filing":"0001225208-21-002096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002096/doc4.xml","form_type":"4"}},{"id":93661,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Performance Share Units","published_at":"2021-02-10T23:47:12.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":11429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date."}],"balance_after":11429,"derivative":{"exercise_date":"2021-02-12","underlying":"Common Stock","underlying_shares":11429},"source":{"system":"sec-edgar","filing":"0001225208-21-002096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002096/doc4.xml","form_type":"4"}},{"id":93660,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-10T23:47:12.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":82127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Awarded under Issuer's Long-Term Incentive Plan."}],"balance_after":82127,"derivative":{"exercise_price":164.62,"exercise_date":"2024-02-08","expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":82127},"source":{"system":"sec-edgar","filing":"0001225208-21-002096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520821002096/doc4.xml","form_type":"4"}},{"id":107666,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Restricted Share Units","published_at":"2020-02-18T22:03:37.000Z","date":"2020-02-13","kind":"exercise","acquired":false,"shares":7724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2020-02-13","underlying":"Common Stock","underlying_shares":7724},"source":{"system":"sec-edgar","filing":"0001225208-20-002666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520820002666/doc4.xml","form_type":"4"}},{"id":107665,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Performance Share Units","published_at":"2020-02-18T22:03:37.000Z","date":"2020-02-13","kind":"exercise","acquired":false,"shares":8360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2020-02-13","underlying":"Common Stock","underlying_shares":8360},"source":{"system":"sec-edgar","filing":"0001225208-20-002666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520820002666/doc4.xml","form_type":"4"}},{"id":107664,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":10441,"kind":"person","name":"Taubert Jennifer L","position":1,"cik":"0001745938","reported_name":"Taubert Jennifer L","relationship":{"officer":true,"officer_title":"EVP, WW Chair, Pharmaceuticals"}}],"security":"Common Stock","published_at":"2020-02-18T22:03:37.000Z","date":"2020-02-13","kind":"tax_withholding","acquired":false,"shares":4277,"price":150.46,"value":643517.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld for payment of taxes upon vesting of Performance Share Units."}],"balance_after":107585.001,"source":{"system":"sec-edgar","filing":"0001225208-20-002666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520820002666/doc4.xml","form_type":"4"}}],"next_cursor":"2020-02-18T22:03:37.000000Z,107664"}